Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HITSTREAM: Platelet/Leukocyte Aggregates in Suspected HIT
NCT06033300Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2023
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoint: Percentage of CD41a+/CD45- platelet clusters at Day 1. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06033300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033300.